To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR
Clinical trial NCT07230184 · COMPLETED
Trial details
- NCT number
- NCT07230184
- Sponsor
- AJU Pharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2023-08-14
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.